TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Shingles Vaccine Antigen
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2015
TELEFLEX ACQUIRES OPTION3’s ATSINA SURGICAL IN ALL-CASH TRANSACTION…
10.29.2015
King’s College London and RCT Establish New Anticancer Drug Discovery Company
10.19.2015
AdvaMed 2015: The MedTech Conference Announces Four Finalists for MedTech Innovator 2015 Competition
9.15.2015
RCT Demonstrates a Hundred-fold Improvement in Penetration of Solid Tumors Using Therapeutic ABDURINS Compared to Antibodies.
8.31.2015
AdvaMed 2015 Issues Call for Transformative Medical Technology Companies to Apply for MedTech Innovator Competition
5.12.2015
DisperSol Technologies Secures over $10 million in Financing Led by RCT
2.3.2015
AdvaMed 2015 Hosts MedTech Innovator Competition
1.12.2015
News by Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
From concept
to market
Innovate with us ›